Forte Biosciences: Millennium reports 3.2% stake

Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander report beneficial ownership of 655,199 shares of Forte Biosciences, Inc. common stock, representing 3.2% of the common stock class.

Rhea-AI Filing Summary

Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander report beneficial ownership of 655,199 shares of Forte Biosciences, Inc. common stock, representing 3.2% of the common stock class.

The reporting persons have no sole voting or dispositive power and instead report shared voting and shared dispositive power over all 655,199 shares. The securities are held by affiliated entities over which they exercise voting control or investment discretion, and they state this disclosure should not itself be construed as an admission of beneficial ownership. They also confirm ownership of 5 percent or less of the class.

Key Figures

Beneficial Ownership: 655,199 shares Ownership Percentage: 3.2 % Shared Voting Power: 655,199 shares +3 more

6 metrics

Beneficial Ownership 655,199 shares Amount beneficially owned by each reporting person in Forte Biosciences common stock

Ownership Percentage 3.2 % Percent of Forte Biosciences common stock class reported owned

Shared Voting Power 655,199 shares Shares over which the reporting persons have shared power to vote or direct the vote

Sole Voting Power 0 shares Shares over which the reporting persons have sole power to vote or direct the vote

Shared Dispositive Power 655,199 shares Shares over which the reporting persons have shared power to dispose or direct disposition

Sole Dispositive Power 0 shares Shares over which the reporting persons have sole power to dispose or direct disposition

Key Terms

beneficially owned, shared voting power, dispositive power, percent of class, +1 more

5 terms

beneficially owned regulatory

"Amount beneficially owned: See response to Item 9 on each cover page."

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

shared voting power regulatory

"Shared Voting Power 655,199.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

dispositive power regulatory

"Shared Dispositive Power 655,199.00"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

percent of class regulatory

"Percent of class: See response to Item 11 on each cover page."

Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

Joint Filing Agreement regulatory

"Exhibit I: Joint Filing Agreement, dated as of July 15, 2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Forte Biosciences (FBRX) shares does Millennium report owning?

Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander report beneficial ownership of 655,199 shares of Forte Biosciences common stock. This position is disclosed collectively for the reporting persons in the Schedule 13G/A amendment.

What percentage of Forte Biosciences (FBRX) does Millennium hold?

The reporting persons state that their Forte Biosciences common stock holding represents 3.2% of the class. They also indicate that they own 5 percent or less of the outstanding class of this security.

What voting and dispositive power does Millennium report over Forte Biosciences (FBRX) shares?

The group reports 0 shares with sole voting or sole dispositive power and 655,199 shares with shared voting power and shared dispositive power. All reported shares are therefore controlled only on a shared basis.

Who are the reporting persons in this Forte Biosciences (FBRX) ownership report?

The Schedule 13G/A identifies three reporting persons: Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander. Each reports the same 655,199 shares and 3.2% beneficial ownership of Forte Biosciences common stock.

How is beneficial ownership of Forte Biosciences (FBRX) shares structured for Millennium?

The securities are held by entities subject to voting control and investment discretion of Millennium Management LLC and/or other managers controlled by Millennium Group Management LLC and Israel A. Englander. They state this structure should not, by itself, be viewed as admitting beneficial ownership.

Where are the principal business offices of the reporting persons in the Forte Biosciences (FBRX) filing?

Millennium Management LLC and Millennium Group Management LLC list their principal business offices at 399 Park Avenue, New York, New York 10022. Israel A. Englander is listed care of Millennium Management LLC at the same address.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/16/2026 - 05:51 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Forte Biosciences, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

34962G208

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 34962G208

1

Names of Reporting Persons

Millennium Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 655,199.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 655,199.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

655,199.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.2 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 34962G208

1

Names of Reporting Persons

Millennium Group Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 655,199.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 655,199.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

655,199.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.2 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 34962G208

1

Names of Reporting Persons

Israel A. Englander

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 655,199.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 655,199.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

655,199.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.2 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Forte Biosciences, Inc.
(b)	Address of issuer's principal executive offices: 3060 Pegasus Park Drive, Building 6, Dallas, Texas 75247
Item 2.
(a)	Name of person filing: Millennium Management LLC Millennium Group Management LLC Israel A. Englander
(b)	Address or principal business office or, if none, residence: Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Group Management LLC 399 Park Avenue New York, New York 10022 Israel A. Englander c/o Millennium Management LLC 399 Park Avenue New York, New York 10022
(c)	Citizenship: Millennium Management LLC - Delaware Millennium Group Management LLC - Delaware Israel A. Englander - United States
(d)	Title of class of securities: Common Stock, par value $0.001 per share
(e)	CUSIP No.: 34962G208
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See response to Item 9 on each cover page.
(b)	Percent of class: See response to Item 11 on each cover page.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See response to Item 5 on each cover page.
	(ii) Shared power to vote or to direct the vote: See response to Item 6 on each cover page.
	(iii) Sole power to dispose or to direct the disposition of: See response to Item 7 on each cover page.
	(iv) Shared power to dispose or to direct the disposition of: See response to Item 8 on each cover page. The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Millennium Management LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	07/15/2026

Millennium Group Management LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	07/15/2026

Israel A. Englander

Signature:	/s/ Israel A. Englander
Name/Title:	Israel A. Englander
Date:	07/15/2026

Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of July 15, 2026, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.